In a time of increasingly bespoke healthcare, Elizabeth Philp has become a formidable force of innovation, particularly in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a movement to make bespoke medications more accessible, disrupting the conventional one